Bio-Rad's Q3 Revenues Increase 2 Percent amid 'Weak' Markets

The firm cited a weak European market in particular for both life sciences and diagnostics as it reported 2 percent revenue growth for the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories